Alternative splicing and nonsense-mediated mRNA decay in neural development

神经发育中的选择性剪接和无义介导的 mRNA 衰减

基本信息

  • 批准号:
    8507514
  • 负责人:
  • 金额:
    $ 8.59万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-04-01 至 2015-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Defects in the nonsense-mediated mRNA decay (NMD) pathway have recently been implicated in multiple neuropsychiatric diseases. However, this pathway has not been well studied in the brain and disruption of NMD in neurons has not been characterized. We recently discovered a novel regulatory role of the NMD pathway in the nervous system. Through coupling to alternative splicing regulation, NMD controls the expression level of postsynaptic density protein 95 (PSD-95), an essential scaffold protein of the excitatory PSD. This mechanism of regulation is similar to the output of transcriptional control, but it is unclear what other natural neuronal transcripts are regulated by NMD. My long term goal is to understand the role of NMD- mediated regulation in the nervous system, and how errors in NMD can lead to neuropsychiatric disorders. The objective of this proposal is to characterize fundamental developmental defects resulting from deficiencies in the NMD pathway and systematically identify physiological NMD substrates in rodent neurons. I have already generated an NMD deficient mouse model and developed various techniques for this proposal. Guided by strong preliminary data, I will pursue two specific aims: 1) Genome-wide identification of NMD targets important for neuronal development; 2) Characterize the physiological requirement for the NMD pathway during development. Based on preliminary data, two important aspects of synapse development, spine morphology and synaptic expression of glutamate receptors, will be examined thoroughly in NMD deficient neurons both in vivo and in vitro. Identification of natural NMD substrates in neurons will shed light on how frequently NMD is used as an active regulatory pathway of gene expression rather than a passive quality-control mechanism. Knowledge about the genetic roles and specific targets of NMD in brain provides a novel perspective for understanding the pathogenesis of various neuropsychiatric diseases and may help point to the common targets/pathways for therapeutic intervention. I have a background in both cellular neuroscience and RNA molecular biology. I am in a unique position to contribute to the proposed research area. To further prepare myself for my long-term research goal, I plan to seek training that will complement my existing technical skills and furthe develop my professional skills. UCLA has a highly collaborative environment ideal to this project and for me to achieve these goals. My mentor, Dr. Douglas Black, is one of the world-class experts in alternative splicing regulation. I also have an advisory committee that consists of Dr. Kelsey Martin, Dr. Tom O'Dell, and Dr. William Yang and provide complementary inputs on neuroscience. My mentor team has a detailed plan to facilitate my research progress and scientific career development. In summary, my educational and research experience together with a strong and supportive mentoring team make me an ideal candidate for this research project and the K99/R00 award.
描述(由申请人提供):无义介导的mRNA衰变(NMD)通路的缺陷最近被认为与多种神经精神疾病有关。然而,这一途径尚未在大脑中得到很好的研究,神经元中NMD的破坏尚未被表征。我们最近发现了NMD通路在神经系统中的一种新的调节作用。通过偶联选择性剪接调节,NMD控制突触后密度蛋白95 (PSD-95)的表达水平,PSD是兴奋性PSD的重要支架蛋白。这种调节机制类似于转录控制的输出,但目前尚不清楚NMD还调节哪些其他天然神经元转录物。我的长期目标是了解NMD介导的调节在神经系统中的作用,以及NMD的错误如何导致神经精神疾病。本提案的目的是表征由NMD通路缺陷引起的基本发育缺陷,并系统地识别啮齿动物神经元中的生理NMD底物。我已经建立了一个NMD缺陷小鼠模型,并为这个提议开发了各种技术。在强有力的初步数据指导下,我将追求两个具体目标:1)全基因组鉴定对神经元发育重要的NMD靶点;2)描述发育过程中对NMD通路的生理需求。基于初步数据,我们将在体内和体外研究NMD缺陷神经元突触发育的两个重要方面,即脊柱形态和谷氨酸受体的突触表达。神经元中天然NMD底物的鉴定将揭示NMD作为基因表达的主动调控途径而非被动质量控制机制的频率。了解NMD在大脑中的遗传作用和特定靶点,为理解各种神经精神疾病的发病机制提供了新的视角,并可能有助于指出治疗干预的共同靶点/途径。我有细胞神经科学和RNA分子生物学的背景。我处于一个独特的位置,可以为拟议的研究领域做出贡献。为了进一步为我的长期研究目标做准备,我计划寻求培训,以补充我现有的技术技能,并进一步发展我的专业技能。加州大学洛杉矶分校有一个高度协作的环境,非常适合这个项目,也适合我实现这些目标。我的导师道格拉斯·布莱克博士,是另一种拼接调节方面的世界级专家之一。我还有一个由Kelsey Martin博士、Tom O'Dell博士和William Yang博士组成的咨询委员会,他们在神经科学方面提供补充意见。我的导师团队有一个详细的计划,以促进我的研究进展和科学事业发展。综上所述,我的教育和研究经历以及一个强大而支持的指导团队使我成为这个研究项目和K99/R00奖的理想人选。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sika Zheng其他文献

Sika Zheng的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sika Zheng', 18)}}的其他基金

The Role of NMD in Cortical Neural Progenitor Cells
NMD 在皮质神经祖细胞中的作用
  • 批准号:
    10572698
  • 财政年份:
    2022
  • 资助金额:
    $ 8.59万
  • 项目类别:
The Role of NMD in Cortical Neural Progenitor Cells
NMD 在皮质神经祖细胞中的作用
  • 批准号:
    10755022
  • 财政年份:
    2021
  • 资助金额:
    $ 8.59万
  • 项目类别:
The Role of NMD in Cortical Neural Progenitor Cells
NMD 在皮质神经祖细胞中的作用
  • 批准号:
    10356466
  • 财政年份:
    2021
  • 资助金额:
    $ 8.59万
  • 项目类别:
The Role of NMD in Cortical Neural Progenitor Cells
NMD 在皮质神经祖细胞中的作用
  • 批准号:
    10532374
  • 财政年份:
    2021
  • 资助金额:
    $ 8.59万
  • 项目类别:
The regulation and function of neuron-specific alternative splicing
神经元特异性选择性剪接的调控和功能
  • 批准号:
    10063921
  • 财政年份:
    2017
  • 资助金额:
    $ 8.59万
  • 项目类别:
The Regulation and Function of Neuron-Specific Alternative Splicing
神经元特异性选择性剪接的调控和功能
  • 批准号:
    10318594
  • 财政年份:
    2017
  • 资助金额:
    $ 8.59万
  • 项目类别:
Alternative splicing and nonsense-mediated mRNA decay in neural development
神经发育中的选择性剪接和无义介导的 mRNA 衰减
  • 批准号:
    8834110
  • 财政年份:
    2014
  • 资助金额:
    $ 8.59万
  • 项目类别:
Alternative splicing and nonsense-mediated mRNA decay in neural development
神经发育中的选择性剪接和无义介导的 mRNA 衰减
  • 批准号:
    9069107
  • 财政年份:
    2014
  • 资助金额:
    $ 8.59万
  • 项目类别:
Alternative splicing and nonsense-mediated mRNA decay in neural development
神经发育中的选择性剪接和无义介导的 mRNA 衰减
  • 批准号:
    8878168
  • 财政年份:
    2014
  • 资助金额:
    $ 8.59万
  • 项目类别:
Alternative splicing and nonsense-mediated mRNA decay in neural development
神经发育中的选择性剪接和无义介导的 mRNA 衰减
  • 批准号:
    8641419
  • 财政年份:
    2013
  • 资助金额:
    $ 8.59万
  • 项目类别:

相似海外基金

Alternative splicing of Grin1 controls NMDA receptor function in physiological and disease processes
Grin1 的选择性剪接控制生理和疾病过程中的 NMDA 受体功能
  • 批准号:
    488788
  • 财政年份:
    2023
  • 资助金额:
    $ 8.59万
  • 项目类别:
    Operating Grants
Using proteogenomics to assess the functional impact of alternative splicing events in glioblastoma
使用蛋白质基因组学评估选择性剪接事件对胶质母细胞瘤的功能影响
  • 批准号:
    10577186
  • 财政年份:
    2023
  • 资助金额:
    $ 8.59万
  • 项目类别:
Long Noncoding RNA H19 Mediating Alternative Splicing in ALD Pathogenesis
长非编码 RNA H19 介导 ALD 发病机制中的选择性剪接
  • 批准号:
    10717440
  • 财政年份:
    2023
  • 资助金额:
    $ 8.59万
  • 项目类别:
RBFOX2 deregulation promotes pancreatic cancer progression through alternative splicing
RBFOX2 失调通过选择性剪接促进胰腺癌进展
  • 批准号:
    10638347
  • 财政年份:
    2023
  • 资助金额:
    $ 8.59万
  • 项目类别:
Alternative splicing regulation of CLTC in the heart
心脏中 CLTC 的选择性剪接调节
  • 批准号:
    10749474
  • 财政年份:
    2023
  • 资助金额:
    $ 8.59万
  • 项目类别:
Nitric oxide as a novel regulator of alternative splicing
一氧化氮作为选择性剪接的新型调节剂
  • 批准号:
    10673458
  • 财政年份:
    2023
  • 资助金额:
    $ 8.59万
  • 项目类别:
Alternative splicing as an evolutionary driver of phenotypic plasticity
选择性剪接作为表型可塑性的进化驱动力
  • 批准号:
    2884151
  • 财政年份:
    2023
  • 资助金额:
    $ 8.59万
  • 项目类别:
    Studentship
Rescuing SYNGAP1 haploinsufficiency by redirecting alternative splicing
通过重定向选择性剪接挽救 SYNGAP1 单倍体不足
  • 批准号:
    10660668
  • 财政年份:
    2023
  • 资助金额:
    $ 8.59万
  • 项目类别:
CAREER: Mechanotransduction, transcription, and alternative splicing in cell biology
职业:细胞生物学中的机械转导、转录和选择性剪接
  • 批准号:
    2239056
  • 财政年份:
    2023
  • 资助金额:
    $ 8.59万
  • 项目类别:
    Continuing Grant
Investigating the role of alternative splicing in the islets of Langerhans in developing diabetes.
研究朗格汉斯岛中选择性剪接在糖尿病发生中的作用。
  • 批准号:
    468851650
  • 财政年份:
    2022
  • 资助金额:
    $ 8.59万
  • 项目类别:
    Research Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了